All In MedTech

FDA Clearance Tracker · P200015-S029

Edwards Commander Delivery System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 4, 2023 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 4, 2023

Approved

Time to decision

207 days

Received Sep 9, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

The decision

FDA number
P200015-S029
Device name
Edwards Commander Delivery System
Applicant location
Irvine, CA
Received
Sep 9, 2022
Decided
Apr 4, 2023
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P200015

Device type

Every decision under product code NPV

FDA's approval statement

As written in FDA's record.

Approval for addition of a new Edwards manufacturing facility located in Limerick, Ireland as an alternate manufacturing site for the Edwards Commander Delivery system sizes 23mm and 26mm.

Source documents

Other decisions for Edwards Lifesciences, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.